Testa U[Author] - Search Results

Year	Number of Results
1978	1
1979	4
1980	14
1981	13
1982	14
1983	7
1984	14
1985	12
1986	7
1987	9
1988	5
1989	11
1990	12
1991	15
1992	13
1993	14
1994	13
1995	12
1996	7
1997	11
1998	9
1999	8
2000	3
2001	4
2002	13
2003	6
2004	7
2005	9
2006	12
2007	10
2008	9
2009	16
2010	12
2011	4
2012	6
2013	5
2014	7
2015	11
2016	6
2017	9
2018	7
2019	9
2020	7
2021	1

1

Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments.

Testa U, Castelli G, Pelosi E. Testa U, et al. Med Sci (Basel). 2020 Mar 23;8(1):18. doi: 10.3390/medsci8010018. Med Sci (Basel). 2020. PMID: 32210163 Free PMC article. Review.

2

CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies.

Testa U, Pelosi E, Castelli G. Testa U, et al. Cancers (Basel). 2019 Sep 12;11(9):1358. doi: 10.3390/cancers11091358. Cancers (Basel). 2019. PMID: 31547472 Free PMC article. Review.

3

Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells.

Testa U, Castelli G, Pelosi E. Testa U, et al. Cancers (Basel). 2018 Jul 27;10(8):248. doi: 10.3390/cancers10080248. Cancers (Basel). 2018. PMID: 30060526 Free PMC article. Review.

4

Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.

Castelli G, Pelosi E, Testa U. Castelli G, et al. Among authors: testa u. Cancers (Basel). 2017 Sep 20;9(9):127. doi: 10.3390/cancers9090127. Cancers (Basel). 2017. PMID: 28930164 Free PMC article. Review.

5

Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.

Testa U, Castelli G, Pelosi E. Testa U, et al. Medicines (Basel). 2019 Jul 30;6(3):82. doi: 10.3390/medicines6030082. Medicines (Basel). 2019. PMID: 31366128 Free PMC article. Review.

6

Oxidative stress and hypoxia in normal and leukemic stem cells.

Testa U, Labbaye C, Castelli G, Pelosi E. Testa U, et al. Exp Hematol. 2016 Jul;44(7):540-60. doi: 10.1016/j.exphem.2016.04.012. Epub 2016 May 12. Exp Hematol. 2016. PMID: 27179622 Review.

7

Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.

Testa U, Lo-Coco F. Testa U, et al. Ann Hematol. 2016 Apr;95(5):673-80. doi: 10.1007/s00277-016-2622-1. Epub 2016 Feb 26. Ann Hematol. 2016. PMID: 26920716 Review.

8

Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.

Testa U, Petrucci E, Pasquini L, Castelli G, Pelosi E. Testa U, et al. Medicines (Basel). 2018 Feb 1;5(1):16. doi: 10.3390/medicines5010016. Medicines (Basel). 2018. PMID: 29389895 Free PMC article. Review.

9

Endothelial Progenitors in the Tumor Microenvironment.

Testa U, Pelosi E, Castelli G. Testa U, et al. Adv Exp Med Biol. 2020;1263:85-115. doi: 10.1007/978-3-030-44518-8_7. Adv Exp Med Biol. 2020. PMID: 32588325 Review.

10

Genetic Alterations of Metastatic Colorectal Cancer.

Testa U, Castelli G, Pelosi E. Testa U, et al. Biomedicines. 2020 Oct 13;8(10):414. doi: 10.3390/biomedicines8100414. Biomedicines. 2020. PMID: 33066148 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results